Founded in 2007, SetPoint Medical started exploring the scientific principles of stimulating the vagus nerve for treatment of autoimmune diseases based on Dr. Kevin Tracey’s pioneering discovery of the Inflammatory Reflex. 

SetPoint Medical’s revolutionary, miniaturized implant is currently undergoing clinical studies in the United States for Rheumatoid Arthritis under IDE clinical study. In parallel, the company has conducted an additional successful proof-of-concept study in Crohn’s disease as well as promising pre-clinical research in multiple sclerosis.